title: OKT3 therapy as a cause of high panel-reactive antibodies in serum using standard microcytotoxicity techniques.
authors.affiliation: Department of Pathology, University of Utah Medical Center, Salt Lake City 84132.
authors.forename: C T
authors.initials: CT
authors.lastname: Wittwer
authors.forename: M R
authors.initials: MR
authors.lastname: Bristow
authors.forename: E M
authors.initials: EM
authors.lastname: Gilbert
authors.forename: D G
authors.initials: DG
authors.lastname: Renlund
authors.forename: J B
authors.initials: JB
authors.lastname: O'Connell
authors.forename: C W
authors.initials: CW
authors.lastname: DeWitt
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000937:Antigen-Antibody Reactions; D003601:Cytotoxicity Tests, Immunologic / Q000379:methods*; D006084:Graft Rejection; D016027:Heart Transplantation; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D051379:Mice; D013601:T-Lymphocytes / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents